This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Achieving and Sustaining Asthma Control in the Community Setting by Combining Clinical Assessment with Enhanced Use of Spirometry

Achieving and Sustaining Asthma Control in the Community Setting by Combining Clinical Assessment with Enhanced Use of Spirometry

Format

Webcast

Time to Complete

1.50 hours

Released

October 15, 2014

Expires

October 14, 2016
Add to Queue


Maximum Credits

1.50 / AMA PRA Category 1 Credit(s)TM
1.50 / Contact Hours (0.15 CEUs)
1.50 / CE for Nurses
1.50 / CE for Nurse Practitioners

Accredited Provider


Jointly provided by AKH Inc., Advancing Knowledge in Healthcare and Not One More Life

Commercial Supporter

Supported by educational grants from AstraZeneca, Boehringer Ingelheim, Meda Pharmaceuticals Inc., and Teva Pharmaceuticals

Program Description

In this activity, experts will review the role of inflammation in both the large and small airways, the pathophysiology of asthma, and use of spirometry for the diagnosis, clinical and physiologic assessment, pharmacologic management, and achieving asthma control.

Intended Audience

This program has been designed for Community pulmonologists, primary care physicians, internal medicine physicians, physician assistants, nurse practitioners, nurses, pharmacists, respiratory therapists, and other health care providers involved in the care of patients with asthma.

Educational Objectives

After completing this activity, clinicians should be better able to:

  • Evaluate the emerging data on the importance small airway function in the pathophysiology of asthma
  • Review the use of spirometry and definition of asthma control for the management of each stage of disease severity
  • Demonstrate strategies to overcome barriers to care and empower patients to better understand and manage their asthma

Conflict Of Interest Disclosure Policy

It is the policy of AKH Inc. and Not One More Life to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by Not One More Life and AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review. AKH Inc. planners and reviewers have no relevant financial relationships to disclose.

Faculty

LeRoy M. Graham, MD, FCCP
Founder and Medical Director
Not One More Life, Inc.
Georgia Pediatric Pulmonology Associates, PC
Morehouse School of Medicine
Atlanta, GA

Dr. Graham has disclosed the following relevant financial relationships:
Speakers bureau: GlaxoSmithKline, Merck & Co., Inc., and Teva Pharmaceuticals.

AKH Staff, Planners, and Reviewers Disclosures

Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner, discloses no financial relationships with pharmaceutical or medical product manufacturers.

Bernadette Marie Makar, MSN, NP-C, APRN-C, Nurse Planner, discloses no financial relationships with pharmaceutical or medical product manufacturers.

Dorothy A. Duffy, B.S. Pharmacy, Pharmacy Reviewer, discloses no financial relationships with pharmaceutical or medical product manufacturers.

AKH planners and reviewers have no relevant financial relationships to disclose.

Credit

1.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Not One More Life. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME.

Credit

1.50

Type

CE for Pharmacists

Accreditation Statement

AKH, Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Designation Statement

AKH Inc. approves this knowledge-based activity for 1.50 contact hour(s) (0.15 CEUs). UAN 0077-9999-14-048-H04-P. Initial Release Date: October 15, 2014.

Credit

1.50

Type

CE for Nurses

Accreditation Statement

AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

This activity is awarded 1.50 contact hour.

Credit

1.50

Type

CE for Nurse Practitioners

Accreditation Statement

AKH, Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education.

Provider Number: 030803

Designation Statement

This program is accredited for 1.5 contact hour(s) which includes 0 hour(s) of pharmacology. Program ID #21420.

This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standard.

Disclosure of Unlabeled Use

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. and Not One More Life specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

Instructions

Statements of credit will be awarded based on the participant’s attendance, participation in the pre/posttest and submission of the activity evaluation form through the online portal at myCME. You must participate in the entire activity to receive credit. There is no fee to participate in this activity.

To fully understand and translate learning, AKH suggests the following methods of active learning for this activity:
  • Develop a matrix to classify the severity of asthma and appropriate treatment therapy
  • List situations where the different treatment options may be advantageous
  • Explore the bibliography and note references to review at a later date.
For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.

If you have questions about this CME/CE activity, please contact AKH Inc. at tbrignoni@akhcme.com.

If you have any other questions relating to your certificate or other issues with the activity, please contact myCME.Support@haymarketmedical.com.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue